Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal Flt3 / CD135 phospho Y589 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CD135, FLK2, STK1, FLT3, Receptor-type tyrosine-protein kinase FLT3, FL cytokine receptor, Fetal liver kinase-2, Fms-like tyrosine kinase 3, Stem cell tyrosine kinase 1, FLK-2, FLT-3, STK-1
- WB
Unknown
Western blot - Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)] (AB171975)
The molecular weight observed is consistent with literature (PMID : 12406902, PMID : 28895560).
This blot was developed using a higher sensitive ECL substrate.
Blocking/Diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)] (ab171975) at 1/1000 dilution
Lane 1:
Untreated A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
A431 was starved overnight then treated with 50mM Pervanadate for 5 minutes whole cell lysate at 15 µg
Lane 3:
A431 was starved overnight then treated with 50mM Pervanadate for 5 minutes, then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 112 kDa
Observed band size: 130 kDa,160 kDa
false
Exposure time: 100s
- WB
Unknown
Western blot - Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)] (AB171975)
All lanes:
Western blot - Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)] (ab171975) at 1/1000 dilution
Lane 1:
A431 cell lysate - untreated at 10 µg
Lane 2:
A431 cell lysate - treated with pervanadate at 10 µg
false
Related conjugates and formulations (1)
-
Anti-Flt3 / CD135 (phospho Y589) antibody [EPR2311(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Flt3 functions as a receptor that is activated by binding to its ligand FLT3 ligand (FLT3L). This interaction stimulates the associated tyrosine kinase activity leading to auto-phosphorylation of Flt3 and subsequent downstream signaling. Flt3 does not form a heterocomplex rather it dimerizes upon ligand binding to initiate signaling cascades. These cascades promote cell proliferation differentiation and survival particularly impacting hematopoiesis and immune responses.
Pathways
Flt3 signaling impacts the internal signaling networks involving the MAPK/ERK and PI3K/AKT pathways both central to cell cycle regulation and apoptosis. Flt3 interacts functionally with proteins such as SHP2 and GRB2 in these pathways aiding signal transduction. The Flt3 receptor also shares functional motifs with KIT and PDGF receptors indicating shared regulatory mechanisms involved in cellular proliferation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 16:1511257 PubMed39963240
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 14:2238-48 PubMed26208525
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com